Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TCRR TCR2 Therapeutics > Main Composition
TCRR TCR2 Therapeutics
1.180
-0.090-7.09%
Post Mkt Price
1.1800.0000.00%
All
YOY
Do not show
Business

No Data

Region

No Data

Company Overview More
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.
CEO: Dr. Garry E. Menzel, PhD
Market: NASDAQ
Listing Date: 02/14/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist